Log in to search using one of your social media accounts:

 

Experts Discuss Unique Side Effects of Immunotherapy
If you have mesothelioma and you’ve already received standard-of-care therapies, you may be considering an immunotherapy clinical trial. If you’re considering this option, a free immunotherapy teleconference is a great place to learn more. CancerCare recently hosted two one-hour education workshops featuring panels of immunotherapy experts. Part I of the teleconference presented an overview of immunotherapy. Part II of the teleconference, which is available online for free, focused exclusively on immunotherapy side effects. Understanding these issues and the role each patient plays in managing their own side ef...
Source: Asbestos and Mesothelioma News - May 21, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Humira does not improve aortic vascular inflammation in psoriasis patients
(University of Pennsylvania School of Medicine) An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation -- a key marker of future risk of major cardiovascular events -- unlike other antibodies that target different aspects of the immune system. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2018 Category: International Medicine & Public Health Source Type: news

Compounds in marijuana may be helpful in alleviating symptoms of eczema and psoriasis
(Natural News) Millions of people around the world struggle with eczema, a common skin condition. Eczema patients have to deal with all sorts of symptoms, but the usual ones include itchiness, red skin, and rashes. Psoriasis patients endure somewhat similar symptoms. Normally, patients of either condition turn to moisturizers and steroid creams to help manage the symptoms.... (Source: NaturalNews.com)
Source: NaturalNews.com - May 11, 2018 Category: Consumer Health News Source Type: news

Biologic Therapies for Psoriasis May Benefit Coronary Arteries Biologic Therapies for Psoriasis May Benefit Coronary Arteries
Three high-risk coronary plaque features improved after 1 year of treatment, independent of statins, other cardiovascular medications, and improvements in risk factors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 8, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Psoriasis Negatively Affects Patient Sleep Quality
MONDAY, May 7, 2018 -- Patients with psoriasis commonly report poor sleep, with itch being the main predictor, according to a study published online April 28 in the British Journal of Dermatology. Peter Jensen, M.D., Ph.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Insight into potential new strategy to target skin diseases like psorias
(UT Southwestern Medical Center) Research at UT Southwestern has shown that targeting metabolism in growing cells holds promise for the treatment of skin diseases like psoriasis that are characterized by skin overgrowth resulting from excess cell division, known as hyperproliferation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 4, 2018 Category: International Medicine & Public Health Source Type: news

ICER reviews on asthma, opioid abuse, plaque psoriasis therapies
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Arthritis pain - eight warning signs of psoriatic arthritis including painful buttocks
ARTHRITIS pain symptoms include inflammation, restricted movement, and joint stiffness. But, these are the warning signs for psoriatic arthritis - a type of arthritis that may develop if you have the skin condition psoriasis. (Source: Daily Express - Health)
Source: Daily Express - Health - April 28, 2018 Category: Consumer Health News Source Type: news

4 Trends Advancing Medtech
For the past 20 years, the Medical Design Excellence Awards have celebrated medical products that improve the quality and accessibility of healthcare. Our finalists this year carry on this tradition, while also keeping in step with today’s high-tech digital and consumer trends. With the help of our esteemed jurors, we have identified four key trends in this year’s group of finalists: risk reduction; faster, more-efficient healthcare delivery; the influence of the Internet of Things; and the consumerization of healthcare. We’ve been tracking a few of these trends in past awards programs, so they’re n...
Source: MDDI - April 27, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M East (New York) Design Source Type: news

Biologics May Chip Away at Clogged Arteries After Just 1 Year (CME/CE)
(MedPage Today) -- Plaque burden stabilized or reduced in patients on psoriasis biologics (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 27, 2018 Category: Cardiology Source Type: news

Ixekizumab Treatment for Psoriasis Ixekizumab Treatment for Psoriasis
This study presents a comprehensive overview of the efficacy of ixekizumab therapy for moderate-to-severe plaque psoriasis, based on two ixekizumab dosing regimens from pivotal phase III studies.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

New study shows therapy for psoriasis can reduce heart plaque
(Society for Cardiovascular Angiography and Interventions) Late-breaking clinical science shows common therapy options for psoriasis (PSO) can help reduce coronary plaque. The authors found that not only do the treatments reduce the volume of the plaque, but also the plaque becomes less inflammatory over time harboring fewer characteristics prone to rupture and cause a heart attack. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2018 Category: International Medicine & Public Health Source Type: news

Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Activated immune cells undergo a metabolic switch to aerobic glycolysis akin to the Warburg effect, thereby presenting a potential therapeutic target in autoimmune disease. Dimethyl fumarate (DMF), a derivative of the Krebs cycle intermediate fumarate, is an immunomodulatory drug used to treat multiple sclerosis and psoriasis. Although its therapeutic mechanism remains uncertain, DMF covalently modifies cysteine residues in a process termed succination. We found that DMF succinates and inactivates the catalytic cysteine of the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in mice and humans, both in vi...
Source: ScienceNOW - April 26, 2018 Category: Science Authors: Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., Snyder, S. H. Tags: Immunology, Medicine, Diseases reports Source Type: news

AbbVie Submits Biologics License Application to U.S. FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis
NORTH CHICAGO, Ill., April 25, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Psoriasis and arthritis sufferers have a higher risk of heart attacks and strokes, study finds
Roxanne Cooksey, a research fellow at Swansea University, explains the clearest ever evidence of a strong link between inflammatory conditions of the skin and bones, and heart woes. (Source: the Mail online | Health)
Source: the Mail online | Health - April 23, 2018 Category: Consumer Health News Source Type: news

Phone App Linked to Improved Psoriasis Treatment Adherence
MONDAY, April 23, 2018 -- A smartphone app is associated with improved short-term adherence to a cutaneous foam treatment for psoriasis, according to a study published online April 14 in the British Journal of Dermatology. Mathias Tiedemann... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2018 Category: Pharmaceuticals Source Type: news

Brodalumab: A Review of Safety Brodalumab: A Review of Safety
This article reviews the publicly available safety data for brodalumab, an interleukin-17R inhibitor approved for chronic plaque psoriasis. Is its safety profile similar to other IL-17 antagonists?Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 23, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Medical News Today: How to beat psoriasis at its own game
Harnessing the power of immune cells, researchers create a compound that successfully treats psoriasis in mice. The innovative approach may also treat MS. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 20, 2018 Category: Consumer Health News Tags: Psoriasis Source Type: news

Novartis CEO feels heat on U.S. generics, Cosentyx drop
ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit. (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Compound treats psoriasis, may curb autoimmune diseases, researchers say
A compound from immune cells treats psoriasis in mice and might also be effective in treating multiple sclerosis, rheumatoid arthritis and lupus. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 18, 2018 Category: Consumer Health News Source Type: news

Oregon grape extract: A natural treatment for psoriasis
(Natural News) Oregon has another reason to be proud of its state flower. The extract of Oregon grape (Mahonia aquifolium) offers a natural way to alleviate the chronic skin condition psoriasis, according to the American Herbalists Guild. As far back as 1900, there have been cases when an individual suffering from psoriasis made a recovery after regularly taking an... (Source: NaturalNews.com)
Source: NaturalNews.com - April 12, 2018 Category: Consumer Health News Source Type: news

Biologics and Biosimilars for Moderate-to-severe Psoriasis Biologics and Biosimilars for Moderate-to-severe Psoriasis
This study compares long-term safety, efficacy, and drug survival data on these agents.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Ardon Health Announces Taltz Distribution
Ardon Health has been selected to Eli Lilly’s Taltz Distribution Network for the treatment of adults with moderate to severe plaque psoriasis and active psoriatic arthritis.(PRWeb April 12, 2018)Read the full story at http://www.prweb.com/releases/2018/04/prweb15401179.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 12, 2018 Category: Pharmaceuticals Source Type: news

Patient Support Program Triumphs
A patient support program offering around the clock assistance to glioblastoma multiforme (GBM) patients undergoing an innovative therapy has been named the Most Valuable Patient Initiative award at eyeforpharma ’s annual awards ceremony in Philadelphia.   Reflecting on the win, Novocure said: “We are humbled to have helped so many patients and to be recognised for it by our peers who have made careers out of trying to help patients in the most need. The eyeforpharma awards are helping pharma to focus on its core constituent — the patient.”  In naming the PSP as the winner of the 2018...
Source: EyeForPharma - April 10, 2018 Category: Pharmaceuticals Authors: Adam Chapman Source Type: news

Medtronic taps Harvard cardiologist Mauri for clinical research VP | Personnel Moves – April 10, 2018
Medtronic (NYSE:MDT) said last week it tapped Harvard Medical School professor and cardiologist Dr. Laura Mauri as its new vice president of global clinical research and analytics. In the new position, Dr. Mauri will direct dynamic global clinical research strategies as well as the development of novel analytical and data science solutions as the Fridley, Minn.-baesd company looks to address “expanding global requirements for clinical evidence for our products.” Dr. Mauri is slated to assume the role on September 1, Medtronic said. Prior to joining Medtronic, Dr. Mauri served as chief scientific officer of...
Source: Mass Device - April 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Avedro Inc. Clarify Medical GE Harvard Henry Schein Medical Mauna Kea Technologies Medtronic milestonescientific Nemaura Medical Omnicell Inc. personnel-moves Second Sight Stryker Source Type: news

Ana ïs Gallagher reveals her psoriasis battle in Instagram post
The 18-year-old British model, who just landed a campaign for the fashion e-tailer Nasty Gal, said the condition, which can cause peeling and flaking skin, makes her 'really self-conscious'. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2018 Category: Consumer Health News Source Type: news

Ask Whats the Best Thing to Put on Psoriasis
What ’s the Best Thing to Put on Psoriasis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 10, 2018 Category: General Medicine Source Type: news

Slide show: Types of psoriasis
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - April 10, 2018 Category: Consumer Health News Source Type: news

Hep C drugs among those accepted today for Scottish NHS
Five new medicines, including treatments for hepatitis C, psoriasis and rheumatoid arthritis, have been approved for use by regulators in Scotland. (Source: Nursing Times)
Source: Nursing Times - April 9, 2018 Category: Nursing Source Type: news

Ask How Does Psoriasis Start Out
How Does Psoriasis Start Out? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 3, 2018 Category: General Medicine Source Type: news

Ask How Do You Get Rid of Psoriasis Naturally
How Do You Get Rid of Psoriasis Naturally? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 3, 2018 Category: General Medicine Source Type: news

Ask Can You Die if You Have Psoriasis
Can You Die if You Have Psoriasis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 3, 2018 Category: General Medicine Source Type: news

Strata Skin Sciences raises $17m, taps Rafaeli as CEO
Strata Skin Sciences (NSDQ:SSKN) said today it raised $17 million in a new round of financing, and that investor Dr. Dolev Rafaeli is slated to take over as interim CEO, with former chief exec Frank McCaney taking the role of interim CFO. In the sale, the Horsham, Penn.-based company said it floated 15.7 million shares of stock. The round was led by Accelmed Growth Partners, who invested $13 million, and joined by Dr. Rafaeli, Gohan Investments, Broadfin Capital and Sabby Management. “We are very pleased to have Accelmed as an investor in Strata. Their experience in medical devices and providing growth equity to...
Source: Mass Device - April 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Strata Skin Sciences Source Type: news

Glenmark gets USFDA nod for psoriasis spray
Glenmark Pharmaceuticals Inc, USA has received final approval by the United States Food& Drug Administration (USFDA) for Clobetasol Propionate spray 0.05 per cent, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2018 Category: Pharmaceuticals Source Type: news

EMA Committee Backs Remicade Biosimilar Zessly EMA Committee Backs Remicade Biosimilar Zessly
The committee favors marketing the infliximab biosimilar product Zessly for treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2018 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Tildra approval to give sentimental push to Sun Pharma
​​The drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune disease. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2018 Category: Pharmaceuticals Source Type: news

FDA Clears Tildrakizumab (Ilumya) for Plaque Psoriasis FDA Clears Tildrakizumab (Ilumya) for Plaque Psoriasis
Tildrakizumab-asmn, a selective interleukin-23 p19 inhibitor given by subcutaneous injection, was shown to be effective for chronic plaque psoriasis in two phase 3 trials.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2018 Category: Consumer Health News Tags: Dermatology News Alert Source Type: news

FDA Approves Ilumya (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
MUMBAI, India and PRINCETON, N.J., March 21, 2018 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Ilumya (tildrakizumab-asmn) for the treatment of adults with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

Ilumya Gets FDA Nod for Plaque Psoriasis
(MedPage Today) -- IL-23 inhibitor treats moderate to severe disease (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 21, 2018 Category: Primary Care Source Type: news

Infections From Ixekizumab in Patients With Psoriasis Infections From Ixekizumab in Patients With Psoriasis
This study investigated the incidence and types of infections associated with ixekizumab.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 21, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Sun Pharma gets USFDA nod for plaque psoriasis drug
The FDA approval of the drug was supported by data from the pivotal phase-3 resurface clinical development program, it said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 21, 2018 Category: Pharmaceuticals Source Type: news

Psoriasis sufferer claims her condition was 'gone' in just 24 hours
Laura Gray, from the North East, suffered from the incurable skin condition for years. Only 'harsh' creams from pharmacists offered her any sort of relief. Then her mother recommended Childs Farm products. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2018 Category: Consumer Health News Source Type: news

Lupin gets USFDA nod for psoriasis treatment spray
Desoximetasone Topical spray, used for treatment of plaque psoriasis, has received approval from the US health regulator for sale in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2018 Category: Pharmaceuticals Source Type: news

A Diagnostic Dilemma: Sometimes You ’ ll Never Know
Patient Presentation A 9-year-old male came to clinic with a 1 month history of painful joint swelling. One month ago he started having right ankle pain that was intermittent but consistent. One day ago his right wrist, right ankle and bilateral knees had some swelling but no erythema or warmth. He says that he has pain in them when he moves but not when he is resting and he denies any joint stiffness or gelling. He also had 1-2 days of multiple red skin lesions on his extremities and trunk, not overlying the affected joints. The skin lesions do not come and go and do not itch. They are mainly discrete circular lesions wi...
Source: PediatricEducation.org - March 19, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Why Cable News And Psoriasis Is A Match Made In Advertiser Heaven
Whether you're a liberal fan of MSNBC or a conservative viewer of Fox, there is no escaping ads for psoriasis treatments. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 16, 2018 Category: Pharmaceuticals Authors: Jonathan Berr, Contributor Tags: NYSE:TWX NASDAQ:CMCSA NASDAQ:FOXA NASADAQ:CELG NASDAQ:ABBV Source Type: news

Could cannabis help treat eczema and psoriasis?
University of Colorado scientists have begun trials on a compound in the drug to determine if it can combat the common skin conditions. (Source: the Mail online | Health)
Source: the Mail online | Health - March 16, 2018 Category: Consumer Health News Source Type: news

Skin Strikes a Balance Between Growth and Integrity
Scientists identify a gene that is linked to skin problems like thickening and peeling and could lead to treatments for skin diseases like psoriasis. (Source: NIDDK News)
Source: NIDDK News - March 15, 2018 Category: Endocrinology Source Type: news

A psoriasis target in Langerhans cells
(Source: ScienceNOW)
Source: ScienceNOW - March 15, 2018 Category: Science Authors: Williams, E. Tags: twis Source Type: news

New Drug Review 2017 New Drug Review 2017
Find out what there is to know about promising new treatments for type 2 diabetes, dermatitis, plaque psoriasis, and asthma.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 14, 2018 Category: Consumer Health News Tags: Pharmacist Journal Article Source Type: news